Abstract
We reanalysed the results of the New Technologies for Cervical Cancer screening (NTCC) study1 separately for women aged 35–49 years and 50–60 years at recruitment. At the first round of screening, the detection ratio for grade 2 cervical intraepithelial neoplasia (CIN) or more severe lesions between the human papillomavirus-screened group (HPV) and the cytology-screened group was 2·31 (95% CI 1·31–4·09) among women aged 50–60 years, and 1·96 (1·51–2·55) among women aged 35–49 years (pheterogeneity=0·61).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
